In traditional monoclonal antibody (mAb) manufacturing, the first purification process step of crude harvest (obtained from cell culture) is Protein-A Chromatography. This expensive column resin is often under-utilized for clinical or orphan drug products since the chromatography columns are dedicated per product…
In traditional monoclonal antibody (mAb) manufacturing, the first purification process step of crude harvest (obtained from cell culture) is Protein-A Chromatography. This expensive column resin is often under-utilized for clinical or orphan drug products since the chromatography columns are dedicated per product…
In traditional monoclonal antibody (mAb) manufacturing, the first purification process step of crude harvest (obtained from cell culture) is Protein-A Chromatography. This expensive column resin is often under-utilized for clinical or orphan drug products since the chromatography columns are dedicated per product…
https://kenx.org/wp-content/uploads/2022/05/Insight-Chart.png371808Jonathan Driscollhttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngJonathan Driscoll2022-05-19 18:59:402022-08-31 22:06:55Innovative considerations for efficient multi-(product) use of Protein-A columns
Stability excursions are unintended lapses in the control parameters (such as temperature, relative humidity, and light) which are designed to preserve a product at experimental, manufacturing, shipping, and patient environment conditions. Significant excursions bring into doubt the validity of data generated in stability studies and the integrity of product during manufacturing and distribution…
Grouping equipment for cleaning validation is a common practice for reducing execution, resources, and production downtime. Though regulatory [1] [2] and industry guidelines [3] support the practice and provide guidance, there is a clear requirement for scientific justification.
As capital projects and technology transfers wrap up and facilities grow nearer to startup, site leaders and team members may be filled with a sense of excitement or dread depending on their confidence in the site’s operational readiness…
https://kenx.org/wp-content/uploads/2020/06/webinar-5-300x215-1.jpg215300EHThttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngEHT2021-08-03 13:11:062021-08-04 16:38:53High Stakes Change Management: Remediation Post FDA Warning Letter
Emerging technologies are quickly playing a greater role in how the Pharmaceutical and Life Sciences Industry collects,
stores and interprets its data…
https://kenx.org/wp-content/uploads/2020/08/kaitlyn-baker-vZJdYl5JVXY-unsplash-scaled.jpg17072560Jonathan Driscollhttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngJonathan Driscoll2021-06-28 00:23:332021-06-28 00:23:33Emerging Technologies in the Pharma and Life Sciences Industry — Mixed Reality
The Food and Drug Administration (FDA) has recently proposed dramatic changes to the current Computerized System Validation (CSV) approach that is being used by most companies in the Life Science Industry...
https://kenx.org/wp-content/uploads/2021/06/image.1.png211432Jonathan Driscollhttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngJonathan Driscoll2021-06-17 00:25:482021-06-17 00:25:48How to Benefit from the Computer Software Assurance Guidance
Software as a Service (SaaS) is a cloud computing delivery model that promises various benefits, but also comes with unique risks. The life science sector has a very slow cloud adoption rate…
https://kenx.org/wp-content/uploads/2021/06/Figure-1.jpg371743EHThttps://kenx.org/wp-content/uploads/2020/07/Insights-Logo22-1.pngEHT2021-06-07 19:08:202021-06-07 19:10:06GxP Considerations for Compliance in the Cloud
Cleaning Validation Program Design: Risk-Based Lifecycle Approach
In traditional monoclonal antibody (mAb) manufacturing, the first purification process step of crude harvest (obtained from cell culture) is Protein-A Chromatography. This expensive column resin is often under-utilized for clinical or orphan drug products since the chromatography columns are dedicated per product…
CIP Cleaning Cycle Development Pitfalls and Solutions
In traditional monoclonal antibody (mAb) manufacturing, the first purification process step of crude harvest (obtained from cell culture) is Protein-A Chromatography. This expensive column resin is often under-utilized for clinical or orphan drug products since the chromatography columns are dedicated per product…
Innovative considerations for efficient multi-(product) use of Protein-A columns
In traditional monoclonal antibody (mAb) manufacturing, the first purification process step of crude harvest (obtained from cell culture) is Protein-A Chromatography. This expensive column resin is often under-utilized for clinical or orphan drug products since the chromatography columns are dedicated per product…
Medical Product Excursions from Labeled Storage Conditions
Stability excursions are unintended lapses in the control parameters (such as temperature, relative humidity, and light) which are designed to preserve a product at experimental, manufacturing, shipping, and patient environment conditions. Significant excursions bring into doubt the validity of data generated in stability studies and the integrity of product during manufacturing and distribution…
Cleaning Validation Equipment Grouping
Grouping equipment for cleaning validation is a common practice for reducing execution, resources, and production downtime. Though regulatory [1] [2] and industry guidelines [3] support the practice and provide guidance, there is a clear requirement for scientific justification.
Role-based Talent Planning for Operational Readiness
As capital projects and technology transfers wrap up and facilities grow nearer to startup, site leaders and team members may be filled with a sense of excitement or dread depending on their confidence in the site’s operational readiness…
High Stakes Change Management: Remediation Post FDA Warning Letter
This is a nontraditional view for understanding and navigating high-stakes change environments, such as FDA Warning Letters….
Emerging Technologies in the Pharma and Life Sciences Industry — Mixed Reality
Emerging technologies are quickly playing a greater role in how the Pharmaceutical and Life Sciences Industry collects,
stores and interprets its data…
How to Benefit from the Computer Software Assurance Guidance
The Food and Drug Administration (FDA) has recently proposed dramatic changes to the current Computerized System Validation (CSV) approach that is being used by most companies in the Life Science Industry...
GxP Considerations for Compliance in the Cloud
Software as a Service (SaaS) is a cloud computing delivery model that promises various benefits, but also comes with unique risks. The life science sector has a very slow cloud adoption rate…